Skip to main content

Day: January 6, 2021

TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference

SAN DIEGO, Jan. 06, 2021 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Virtual BioConnect 2021 Conference, being held January 11-14, 2021.The presentation will be available on-demand beginning on Monday, January 11, 2021, in the Investors section on the Company’s website at www.traconpharma.com.About TRACONTRACON develops targeted therapies for cancer utilizing a capital efficient,...

Continue reading

Aurskog Sparebank: Innkalling til valgmøte for egenkapitalbeviseiere

Det innkalles til valgmøte for bankens egenkapitalbeviseierne onsdag 27. januar 2021 kl 19:30 i Aurskog Sparebanks hovedkontor, Senterveien 15, 1930 Aurskog. Skriftlig innkalling er sendt alle egenkapitalbeviseiere på innkallingstidspunkt. Møteinnkalling med tilhørende dokumenter følger vedlagt.VedleggInnkalling valgmote egenkapitalbeviseiere 270121

Continue reading

DZS to Present at the 23rd Annual Needham Growth Conference

PLANO, Texas, Jan. 06, 2021 (GLOBE NEWSWIRE) — DZS Inc. (NASDAQ: DZSI), a global leader of mobile, fixed broadband and enterprise access networking solutions representing 1,000+ communications service providers and enterprise customers, today announced that Charlie Vogt, Chief Executive Officer, and Tom Cancro, Chief Financial Officer, will present at the 23rd Annual Needham Growth Conference on Monday, January 11, 2021 at 9:15 a.m. ET. DZS will provide an audio webcast on the Investor Relations section of the DZS website at https://investor-dzsi.com.About DZSDZS Inc. (NSDQ: DZSI) is a global leader of mobile, fixed broadband and enterprise access networking and transport solutions with 20+ million products deployed across 1,000+ communication service providers and enterprise customers spanning 100+ countries.DZS, the DZS logo,...

Continue reading

LexaGene to Present at Upcoming SNN Network and H.C. Wainwright Bioconnect 2021 Virtual Events

BEVERLY, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce that it will be presenting at two upcoming investor conferences.Dr. Jack Regan, CEO and Founder of LexaGene, will be presenting at the SNN Network Canada Virtual Event on Thursday January 7th, 2021 at 1:30pm (Eastern Time). To access LexaGene’s live presentation, please use the following link: https://www.webcaster4.com/Webcast/Page/2059/39313. The Company’s webcast presentation will be available directly on the conference event platform under the agenda tab after the event.Dr. Regan will also be presenting at the H.C. Wainwright Bioconnect 2021 Virtual Conference. The conference is on-demand and...

Continue reading

US Department of Justice Division Leverages BIO-key’s PortalGuard Solution for Secure Authentication

WALL, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced that a US Department of Justice division is using BIO-key’s PortalGuard IAM solution for secure authentication and access to systems.BIO-key’s PortalGuard IAM solution provides strong multi-factor authentication while reducing user frustration and help desk related costs for customers. PortalGuard meets or exceeds the strictest authentication requirements and facilitates IT resource cost reduction goals.“Our team is extremely proud to support this vital national security program,” said Mark Cochran, President of BIO-key – PortalGuard. “The BIO-key team has extensive experience supporting many of our national...

Continue reading

Inovalon to Present at 23rd Annual Needham Growth Conference

BOWIE, Md., Jan. 06, 2021 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D., chief executive officer and chairman of the board of Inovalon, and Jonathan R. Boldt, chief financial officer of Inovalon, will present at the 23rd Annual Needham Growth Conference, which will be held virtually.The virtual presentation will take place at 11:30 a.m. (EST) on Wednesday, January 13, 2021. Investors may access a live audio webcast of the presentation on the Investor Relations section of Inovalon’s website at www.inovalon.com. An archived version will remain posted for a limited time.About InovalonInovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform, Inovalon...

Continue reading

COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences

London, UK, Jan. 06, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of its management team will participate in two investor conferences during the week of 11 January 2021.  George Goldsmith, Chairman, CEO and Co‑founder, and Lars Wilde, President, Chief Business Officer, and Co‑founder, will be participating in a fireside chat available on demand from 11 to 14 January in conjunction with the HC Wainwright BioConnect 2021 Conference.George Goldsmith and Lars Wilde will also present a business update and hold a fireside chat at 12:15 pm ET on 14 January at the Westwicke Healthcare Day at the ICR Conference 2021.Audio webcasts of the fireside chats will be available on the “Events”...

Continue reading

Emerita Resources Provides Update on Drill Permitting at Iberia Belt West Project, Spain

TORONTO, Jan. 06, 2021 (GLOBE NEWSWIRE) — Emerita Resources Corp. (TSX-V: EMO) (the “Company” or “Emerita”) has engaged FRASA Ingenieros Consultores (“FRASA”), a highly reputable engineering firm with offices in Spain and Internationally, to prepare the environmental documentation for the Iberia Belt West (“IBW”) Project (the “Project”) in order to obtain the “Autorizacion Ambiental Unificada (AAU)”.   FRASA are the Environmental Consultants used by major companies in the area for permitting and are well versed in the requirements to obtain work permits. The AAU is the environmental license required in the area for exploration activities. The Project is within the renowned Iberian pyrite belt, an area with numerous past producing and active mining operations currently operating under the same well established environmental statutes....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.